Curex vs HealthSource
Two GLP-1 desks, one scoreboard. We put Curex and HealthSource head-to-head on the published Brief Score — the same six factors, scored the same way.
Curex
FDA warning letter, September 2025 — issued to Curex. See the FDA's warning letter database.
The verdict
Curex takes this head-to-head.
Curex scores 86 to 79 on our six-factor Brief Score — Identical $199 pricing on both molecules, an oral route, LegitScript-certified and nationwide.
That doesn't make HealthSource a bad call — it's best for readers who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Curex | HealthSource | |
|---|---|---|
| Brief Score | 86/100 (B) | 79/100 (C) |
| Semaglutide | $199/mo | From $199/mo (all doses, compounded) |
| Tirzepatide | $199/mo | From $299/mo (all doses, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
Curex: Flat $199 on both molecules; LegitScript-certified and nationwide.
HealthSource: New to the tracker on 1 August 2026. The published line reads From $199/mo (all doses, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.